| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2113861 | Cancer Letters | 2011 | 8 Pages |
Abstract
Biliverdin reductase (BVR) converts biliverdin to bilirubin. Additionally, acting as a transcription factor and possessing a capacity of a serine/threonine kinase, it may modulate signaling pathways. In order to gain better understanding of BVR functions, we used genetically modified line of mouse fibroblasts with reversible overexpression of BVR.Current study revealed that enhanced activity of BVR may protect cells in stressful conditions arising from anti-cancer drugs, cisplatin and doxorubicin, the effect most probably related to PKC α/β activity, as its inhibition reversed BVR action. Therefore activity of BVR may be of significance in tumors and may influence the effectiveness of therapies.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Urszula Florczyk, Slawomir Golda, Agata Zieba, Jaroslaw Cisowski, Alicja Jozkowicz, Jozef Dulak,